Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. It offers chemiluminescence immunoassay analyzer, diabetes instruments and related reagents, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China.
Frequently asked questions
What sector does Shenzhen YHLO Biotech Co. Ltd. A (688575) operate in?
Shenzhen YHLO Biotech Co. Ltd. A belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Shenzhen YHLO Biotech Co. Ltd. A (688575) current stock price?
As of the latest data, Shenzhen YHLO Biotech Co. Ltd. A stock price is CN¥9.57, with a previous close of CN¥9.76. Shenzhen YHLO Biotech Co. Ltd. A lost -CN¥0.19 in the last trading session, representing a -1.95% loss.
What is Shenzhen YHLO Biotech Co. Ltd. A (688575) current market capitalization?
Shenzhen YHLO Biotech Co. Ltd. A market cap is approximately 5.47 billion.
What is Shenzhen YHLO Biotech Co. Ltd. A (688575) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.11, and the forward EPS is CN¥0.49.
What is Shenzhen YHLO Biotech Co. Ltd. A (688575) Price-to-Earnings (P/E) ratio?
Shenzhen YHLO Biotech Co. Ltd. A current P/E ratio is 87, with a forward P/E of 19.66.
Does Shenzhen YHLO Biotech Co. Ltd. A (688575) pay dividends?
Yes. Shenzhen YHLO Biotech Co. Ltd. A pays annual dividends with an annualized yield of 0.22% and an estimated annual payout of CN¥0.02 per share.
When is the next ex-dividend date for Shenzhen YHLO Biotech Co. Ltd. A (688575)?
The next ex-dividend date is scheduled for June 12, 2027.
What is Shenzhen YHLO Biotech Co. Ltd. A (688575) beta (volatility) score?
Shenzhen YHLO Biotech Co. Ltd. A has a beta of 0.191, indicating lower volatility than the overall market.